M.CammerM.NeilJ.et al (2017)
However, whether LT4 administration is also able to restore FT3 values and whether decrements in FT3 that remain within the reference range are actually of any clinical significance is a matter of controversy (28, 38)
(The agency has not announced that it intends to do so.) Ultimately, what we would hope is, before the end of the year, patients would be able to go to their doctor, work through maybe a telehealth provider, and then be able to get a prescription for this under monitored medical supervision, he said
It goes with absolutely everything
J Pharmacol Exp Ther 321(3):892901
In some embodiments, the otic formulation or composition comprises between about 0.01% to about 70% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof